-
Recruiting
NCT NCT05456503
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Not yet reported
University of Pennsylvania
72 participants
Est. completion 2028-08
1 site
Other conditions: Frontotemporal Lobar Degeneration, Alzheimer Disease, Cognitively Normal
View official trial listing →
-
Recruiting
NCT NCT05641688
[18F]PI-2620 Phase 3 Histopathological Study
Not yet reported
Lantheus Biosciences Ltd.
200 participants
Est. completion 2027-06
25 sites
Other conditions: Alzheimer Disease
View official trial listing →
-
Recruiting
NCT NCT05847192
Tau Networks in Psychotic Alzheimer's Disease
Northwell Health
91 participants
Est. completion 2029-12-31
1 site
Other conditions: Alzheimer Disease, Alzheimer Disease With Delusions, Alzheimer Disease With Psychosis
View official trial listing →
-
Recruiting
NCT NCT06336382
Tau Biomarkers in Late-onset Psychosis (LOP)
Jeremy Koppel
16 participants
Est. completion 2027-06-30
1 site
Other conditions: Late Onset Schizophrenia, Delusional Disorder (Late Onset)
View official trial listing →
-
Recruiting
NCT NCT07020026
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
Not yet reported
Michael J. Fox Foundation for Parkinson's Research
60 participants
Est. completion 2027-06
1 site
Other conditions: Parkinson's Disease
View official trial listing →
-
Completed
NCT NCT03510572
Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain
Not yet reported
Asan Medical Center
20 participants
Est. completion 2019-07-31
1 site
Other conditions: Healthy Volunteer, Alzheimer Disease, Frontotemporal Dementia, Parkinson Disease
View official trial listing →
-
Completed
NCT NCT03903211
Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease
Not yet reported
Jae Seung Kim
84 participants
Est. completion 2021-02-28
1 site
Other conditions: Cognitively Normal, Mild Cognitive Impairment, Alzheimer Disease
View official trial listing →
-
Active, not recruiting
NCT NCT04251130
Linking Tau PET to Medial Temporal Lobe Subregions With High Resolution MRI
University of Pennsylvania
150 participants
Est. completion 2028-01
1 site
Other conditions: Mild Cognitive Impairment
View official trial listing →
-
Completed
NCT NCT04566003
Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease
Not yet reported
Genentech, Inc.
40 participants
Est. completion 2023-06-27
1 site
Other conditions: Alzheimer Disease (AD)
View official trial listing →
-
Completed
NCT NCT04715750
Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity
Not yet reported
Life Molecular Imaging GmbH
10 participants
Est. completion 2022-10-26
1 site
Other conditions: Alzheimer Disease, Progressive Supranuclear Palsy
View official trial listing →
-
Completed
NCT NCT04906590
PPMI Tau PET Imaging
Not yet reported
Michael J. Fox Foundation for Parkinson's Research
23 participants
Est. completion 2023-02-01
1 site
Other conditions: Parkinson Disease
View official trial listing →
-
Completed
NCT NCT05187546
Test-retest Study With [18F]PI-2620 in PSP-RS and NDC
Not yet reported
Life Molecular Imaging GmbH
15 participants
Est. completion 2024-03-05
1 site
Other conditions: Progressive Supranuclear Palsy
View official trial listing →
-
Terminated
NCT NCT05337774
Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
Not yet reported
Lantheus Biosciences Ltd.
18 participants
Est. completion 2022-04-30
1 site
Other conditions: Mild Traumatic Brain Injury
View official trial listing →
-
Status unknown
NCT NCT05490576
Tau And Connectomics In TES Study
Not yet reported
Macquarie University, Australia
12 participants
Est. completion 2024-12-31
1 site
Other conditions: Chronic Traumatic Encephalopathy, Traumatic Encephalopathy, Head Injury Trauma, Cognitive Impairment, Neurodegenerative Diseases
View official trial listing →
-
Enrolling by invitation
NCT NCT05617014
Alzheimer's Disease Neuroimaging Initiative 4
University of Southern California
1500 participants
Est. completion 2027-07-31
65 sites
Other conditions: Mild Cognitive Impairment, Alzheimer Disease, Dementia
View official trial listing →
-
Completed
NCT NCT05651516
Tau PET Imaging in Opioid Use Disorder
Not yet reported
University of Pennsylvania
12 participants
Est. completion 2026-06-02
1 site
Other conditions: Opioid-Related Disorders
View official trial listing →
-
Completed
NCT NCT06224920
Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease
Ludwig-Maximilians - University of Munich
140 participants
Est. completion 2024-01-01
Other conditions: Alzheimer Disease, Corticobasal Syndrome
View official trial listing →
-
Active, not recruiting
NCT NCT07105384
Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy
Not yet reported
Fundacion Clinic per a la Recerca Biomédica
66 participants
Est. completion 2028-12-20
1 site
Other conditions: Parkinson Disease
View official trial listing →
-
Active, not recruiting
NCT NCT07503743
Biology-Driven Cognitive Profiling in Huntington's Disease
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
90 participants
Est. completion 2026-07
1 site
Other conditions: Huntington's Disease (HD)
View official trial listing →
